Abstract:Turning early-cancer diagnosis into actionable treatment often relies on highly accurate and sensitive imaging techniques to guide surgical intervention or to monitor therapeutic efficacy. Earli is developing a highly sensitive, orthogonal approach that uses genetic constructs to usurp dysregulated cancer pathways to force the tumor to produce a PET reporter gene, enabling the use of radiotracers amenable to positron emission tomography/computed tomography (PET/CT) to guide precision imaging. However, analysis of PET/CT images using standard manual and semi-automated methods is challenging resulting in reduced experimental throughput and user variability, highlighting the need for a fully automated PET/CT analysis pipeline using Deep Learning (DL). To increase pre-clinical throughput and reduce inter-user variability, we developed an automated DL processing pipeline in Python to perform three major tasks: separation of multi-mouse bed data for PET uptake quantification by mouse, segmentation of tumors and background organs, and quantification of PET signal for PK/PD analysis. Preclinical PET/CT data was acquired using a 4 animal, multi-mouse bed and separated into individual mice by co-registering the reconstructed CT image against a multi-mouse bed reference mask using a rigid 3D Euler transformation algorithm and cropping at fixed indices. Following mouse separation, a 3D nnUNet architecture is used to perform semantic segmentation of regions of interest (ROI) on CT for bi-hemispheric subcutaneous tumors, lungs, liver, kidneys, spleen, and the bladder. nnUNet was trained on PET/CT of 311 mice consisting of a mixture of naïve and tumor-bearing animals subcutaneously implanted with H1299 cells using a five-fold cross-validation strategy with 1000 epochs per fold. Model performance was evaluated by comparing the network prediction to the reference manually annotated masks using the Dice coefficient. PET uptake is reported as percent injected dose per milliliter (%ID/mL) or standardized uptake value (SUV). Segmentation performance results for the hold-out set identified mean Dice scores greater than 0.80 for all ROIs, reflecting the similarity between model predictions and human annotations. The automated pipeline reduced the analysis time from 5.5-6 hours per mouse when using traditional manual/semi-automatic approaches to approximately 15 minutes. In summary, we developed a fully automated DL-based PET/CT quantification pipeline for pre-clinical mouse studies that provides accurate ROI segmentation and PET uptake quantification, significantly increasing experimental throughput and reducing inter-user variability. Further improvements to model inference include loss functions weighted for poor performing ROIs and addition of lung nodule segmentation for eventual translation to humans as an accompaniment to Earli's theranostic programs. Citation Format: Hung-Yu Henry Lee, Mohammed Goryawala, Tim Sproul, Maggie Louie, David Suhy. Leveraging deep learning for fully automated analysis of pre-clinical mouse positron emission tomography [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 3529.

The impact of introducing deep learning based [18F]FDG PET denoising on EORTC and PERCIST therapeutic response assessments in digital PET/CT

An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms

PET Image Denoising Using Unsupervised Deep Learning.

Comparative effectiveness of standard vs. AI-assisted PET/CT reading workflow for pre-treatment lymphoma staging: a multi-institutional reader study evaluation

Denoising approaches by SubtlePETTM artificial intelligence in positron emission tomography (PET) for clinical routine application

Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT

Full-Dose PET Image Estimation from Low-Dose PET Image Using Deep Learning: a Pilot Study

Clinical Evaluation of Deep Learning for Tumor Delineation on 18 F-FDG PET/CT of Head and Neck Cancer

Phantom-based image quality assessment of clinical 18F-FDG protocols in digital PET/CT and comparison to conventional PMT-based PET/CT

Automated F18-FDG PET/CT image quality assessment using deep neural networks on a latest 6-ring digital detector system

Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis

Nuclear medicine technologists practice impacted by AI denoising applications in PET/CT images

Investigation of Lesion Detectability Using Deep Learning Based Denoising Methods in Oncology PET: a Cross-Center Phantom Study

Low 18F-Fluorodeoxyglucose Dose Positron Emission Tomography Assisted by a Deep-Learning Image-Denoising Technique in Patients with Lymphoma.

Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN

Contrast-enhanced small-animal PET/CT in cancer research: strong improvement of diagnostic accuracy without significant alteration of quantitative accuracy and NEMA NU 4–2008 image quality parameters

A Cross-Scanner and Cross-Tracer Deep Learning Method for the Recovery of Standard-Dose Imaging Quality from Low-Dose PET

Non-invasive measurement of PD-L1 status and prediction of immunotherapy response using deep learning of PET/CT images

3D Full-Dose Brain-Pet Volume Recovery from Low-Dose Data Through Deep Learning: Quantitative Assessment and Clinical Evaluation

Exploring feature-based approaches in PET images for predicting cancer treatment outcomes

Abstract 3529: Leveraging deep learning for fully automated analysis of pre-clinical mouse positron emission tomography